Cargando…
Outcomes of Pediatric Patients with Crohn's Disease Received Infliximab or Exclusive Enteral Nutrition during Induction Remission
BACKGROUND: Both exclusive enteral nutrition (EEN) and infliximab (IFX) are recommended as induction therapy for pediatric Crohn's disease (CD). Our aim was to compare long-term disease outcomes of patients initially received with either IFX or EEN. METHODS: Medical records of newly diagnosed,...
Autores principales: | Lv, Yao, Lou, Yue, Yang, Gan, Luo, Youyou, Lou, Jingan, Cheng, Qi, Yu, Jindan, Fang, Youhong, Zhao, Hong, Peng, Kerong, Chen, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462978/ https://www.ncbi.nlm.nih.gov/pubmed/36089982 http://dx.doi.org/10.1155/2022/3813915 |
Ejemplares similares
-
Exclusive Enteral Nutrition versus Infliximab in Inducing Therapy of Pediatric Crohn's Disease
por: Luo, Youyou, et al.
Publicado: (2017) -
Short-Term Efficacy of Exclusive Enteral Nutrition in Pediatric Crohn's Disease: Practice in China
por: Luo, Youyou, et al.
Publicado: (2015) -
One Case of Epstein–Barr Virus Encephalitis from Pediatric Crohn’s Disease After 6-Mercaptopurine and Infliximab Treatment
por: Yu, Jindan, et al.
Publicado: (2023) -
Pediatric radiation enteritis with intestinal failure: A case report and literature review
por: Xu, Luojia, et al.
Publicado: (2020) -
Infliximab for medical induction of remission in Crohn's disease
por: Gordon, Morris, et al.
Publicado: (2023)